Showing results (311-320 of 411) with videos related to

Sort By:
Pageof 42
Epigenomics|June 26, 2015
DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohortsLeonidas Chouliaras, Gunter Kenis, Pieter Jelle Visser, et al.
Journal of the American Geriatrics Society|December 23, 2011
Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the Development of Screening guidelines and diagnostic Criteria for Predementia Alzheimer's disease studySietske A M Sikkes, Pieter Jelle Visser, Dirk L Knol, et al.
Frontiers in Aging Neuroscience|August 25, 2015
Gains in cognition through combined cognitive and physical training: the role of training dosage and severity of neurocognitive disorderPanagiotis D Bamidis, Patrick Fissler, Sokratis G Papageorgiou, et al.
Alzheimer'S Research & Therapy|March 3, 2025
Synaptic protein CSF levels relate to memory scores in individuals without dementiaKirsten E J Wesenhagen, Diederick M de Leeuw, Jori Tomassen, et al.
Scientific Reports|December 11, 2020
Urinary metabolic phenotyping for Alzheimer's diseaseNatalja Kurbatova, Manik Garg, Luke Whiley, et al.
BMJ Open|July 21, 2016
European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flowOlga Meulenbroek, Sarah O'Dwyer, Daan de Jong, et al.
Brain : a Journal of Neurology|January 13, 2021
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomicsBetty M Tijms, Johan Gobom, Lianne Reus, et al.
Journal of Alzheimer'S Disease : JAD|June 20, 2018
Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain BiomarkersMoira Marizzoni, Clarissa Ferrari, Jorge Jovicich, et al.
Frontiers in Aging Neuroscience|July 11, 2018
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative DataIsabelle Bos, Stephanie J B Vos, Willemijn J Jansen, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2018
Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI StudyDiego Albani, Moira Marizzoni, Clarissa Ferrari, et al.
Pageof 42